ACE and hypertensive disorder: Extensive preclinical data support the potential use of angiotensin II receptor blockers (ARBs) and angiotensin I converting enzyme (ACE) inhibitors, two common classes of medications FDA approved for the management of hypertension [4], as antineoplastic agents in PC.